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Objectives. To explain the discrepancy between the symptom-
atic status of patients and the hemodynandcally calculated mitral
valve area during long-form follow-up after mitral balloon valvu .
lolonly, witral valve orifice variability after d0bufamine infusion
was Investigated in two groups of patients.
Background. A significant increase in aortic valve area with
increased aortic transvaivular flow has been reported in patients
with calelfie aortic stenosis after aortic balloon vaivulatomy . A
similar phenomenon with regard to the mitral valve has not been
studied in detail .
Methods. Group 1 comprised 10 patients (mean age 33 ± 9
years) with untreated mitral stenosis . Group 2 comprised 29
consecutive patients (mean age 32 ± 7 years) who underwent
successful percutaneous mitral balloon valvulotomy 13 ± 2
months before the study .
Results. After dobutamine infusion, heart rate and cardiac
index increased significantly in both gnup . The mean pulmonary
artery pressure, mitral valve gradient and pulmonary capillary
pressure remained unchanged in Group 2 but increased signifi-
Percutaneous mitral valvulotomy is an alternative to surgical
mitral commissurotomy in selected patients with mitral
stenosis. There is no universally accepted definition of
restenosis after percutaneous mitral valvulotomy. The re-
ported rates for restenosis detected by hemodynamic and
echocardiographic measurements have varied between 0%
(1) and up to 70% in patients with a poor echocardiographic
mitral valve score (2) . Clinical restenosis, defined as a
recurrence of symptoms or death, was reported to be 16% in
the M-Heart study (3) . We previously reported restenosis,
defined as mitral valve area :5 1 .5 cm
2
with 50% loss of gain,
in 18% of 115 patients who were examined by Doppler
echocardiography 18 ± 7 months after successful balloon
valvulotomy (4) . We also noted that 60% of the patients with
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cantly in Group 1 . The mean mitral valve area was signif- . :_ndy
larger in Group 2 after dobutamine infusion than at b: : . zlirt
(1 .9 ± 0.5 vs. 2A ± OA Q% p < 0.0001) but was unchar J in
Group 1 (1.2 ± 0.2 vs. 1 .3 ± 0.3 &, p = NS). `fhe mean `' cal
valve area in seven patients in Group 2 (24%) was :51.5 cm2
before dobutamine infusion (1 .3 ± 0.4 cm2), which was defined as
restenosis . In five of these seven patients who had minimal or no
the mitral valve area increased significantly after
dobutamine infusion (1 .3 ± 0.1 vs . 1 .9 ± 0 .1 cm2) . In the other
two patients who were symptomatic, the mitral valve area did W
change after dobutamine infusion . These two patients were iden-
tified as having "true" restenosis, and redilation of the initral
valve was performed in both.
Conclusions. In patients who underwent mitral balloon valvu-
lotomy, increased mitral valve reserve capacity contributed to
symptomatic improvement on long-term follow . up. Dobutsmine
infusion may be helpful in detecting clinically significant resteno-
sis .
(J Am Coll Cardiol 1993,22 :1691-6)
restenosis still had symptomatic improvement by >1 New
York Heart Association functional class during the follow-up
period. One possible explanation for this discrepancy may
be an increase in mitral valve area with higher transmitral
blood flow in conditions such as exercise . A significant
increase in aortic valve area with increased aortic ti -ansval-
vular flow was reported by Paulus et al . (5) in patients with
calcific aortic stenosis after aortic balloon valvulotomy . A
similar phenomenon with regard to the mitral valve has not
been studied in detail
. Therefore, we investigated mitral
valve orifice variability after dobutamine infusion in a group
of patients with successful balloon valvulotomy and com-
pared the results with t,ose in a group of patients with
untreated mitral stenosis .
Methods
Study groups
. The study was performed in two groups of
patients with mitral stenosis
. Group I comprised 10 patients
(9 women, I man
; mean age 33 ± 9 years) with untreated
mitral stenosis . Group 2 comprised 29 consecutive patients
0735-10971931$6 .0O
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(27 women, 2 men
; mean age 32 ± 7 years) who underwent
successful percutaneous mitral balloon valvulotomy with
the double-balloon technique 13 ± 2 months before the
study. All patients in Group I and 26 patients in Group 2 had
normal sinus rhythm . Two patients in Group I and three
patients in Group 2 had mild aortic regurgitation; three pa-
tients in Group 2 had mild mitral regurgitation . Eight patients
in Group I were in New York Heart Association functional
class Ill and two were in class II. Two patients in Group 2
were in functional class III, 9 were in class 11 and 18 were in
class 1 .
t;chocardiegrapldc findings
. The mean echocardio-
graphic score was 5 .9 ± 0.7 and 6.0 ± 1 .3 in groups I and 2,
respectively (p .> 0.05), according to the method of Wilkins
et al . (6) .
i)rkmat;amlne stress est protocol . Written informed con-
sent approved by the human
studies committee of our
hospital was obtained from each patient . After standard right
and left heart cardiac catheterization and left ventriculogra-
phy, dobutamine infusion was started at a rate of 5 µg/kg
body weight per min and was increased gradually by 5 tg/kg
per tin every 3 min until either the target heart rate
(maximal exercise heart rate for age) or the maximal dose of
25 AgU per min was reached, or symptoms occurred .
Pulmonary artery and pulmonary wedge pressures were
measured by a 7F thermal dilution balloon-tipped flotation
catheter (Waters Laboratory), and left ventricular pressure
was measured by a 7F pigtail (Cordis) catheter using
Statham P23 ID pressure transducers and a Polygraph
(Nihon Kohden) recorder. Cardiac output by thermal dilu-
tion was obtained (the aver of five measurements), and a
diagnostic oxygen test (superior vena cava [SVC] and infe-
rior vena caava (1VCI samples were used to calculate the
mitred , venous saturation according to the formula (3 SVC +
11VCJ/4) was performed to assess the presence of a left to
rot shunt at baseline and at the peak infusion dose of
tamine. Symptoms, the electrocardiogram (ECG) and
pulmonary artery and left ventricular pressures were moni-
tored continuously throughout the infusion period . The
mean mitral valve gradient was determi3icd by planimetry of
the area between the pulmonary wedge pressure and the left
ventricular diastolic pressure of six cardiac cycles recorded
at a paper speed of 50 mm/s at high gain . The mitral valve
area was calculated by the Gorlin formula (7). Mitral valve
resistance (R) was calculated by the formula R
M
Mitral
valve flow/Mean mitral gradient, Restenosis in Group 2
patients who underwent mitral valvulotomy was arbitrarily
defined as mitral valve area X1,5 cm2 and a loss of a_-S0° of
the dt aitt in mitral valve area achieved at percutaneous mitral
valvulotomy .
c
'tread is. A two-factor repeated measures anal-
ysis of variance was used to detect statistical differences
between rest values and values after dobutamine infusion on
a Macintosh Classic computer using Statview 512 . A p value
< 0.05 was accepted as statistically significant .
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Results
The mean dobutamine dose was 16 t 4 .6 Vg/kg per min in
Group I (untreated mitral stenosis) and 21 .8 ± 3.3 ,erg,/kg per
min in Group 2 (previous successful balloon valvulotomy)
(p < 0.005) . Eighteen of the 29 patients in Group 2, but only
I of the 10 patients in Group l, received the maximal dose of
25 pg/kg per min. In 6 of the 10 patients in Group 1,
dobutamine infusion was terminated because symptoms
occurred before the maximal heart rate was reached . No
patients developed pulmonary edema, angina or ventricular
tachycardia . In eight patients (three in Group I and five in
Group 2), chills and nausea developed but were not severe
enough to require stopping the infusion .
Dobutamine infusion significantly increased heart rate
and cardiac index in both groups (Tables I and 2) . The mean
pulmonary artery pressure, mitral valve gradient and pulmo-
nary capillary pressure remained unchanged in Group 2 but
increased significantly in Group 1 . The mitral valve area
increased significantly in Group'-' (1 .9 * 0.5 vs . 2 .4 t 0.6 cm2 ,
p < 0.0001) but was unchanged in Group 1 (1 .2 t 0.2 vs . 1 .3 t
0.3 cm', p
m
NS) (Fig . I and 2). Mitral valve resistance
increased in Group I and decreased in Group 2 .
The mean mitral valve area in seven patients in Group 2
(24%) was 1 .S cm2 before dobutamine infusion (1 .3 ±
0.4 cm'), which was defined as restenosis . The mean
echocardiographic score in these patients was 6 .4 `±° 0.7 (p
NS vs. the rest of Group 2) . Of these seven patients, five had
minimal or no symptoms after mitral balloon valvulotomy .
In these five patients the mitral valve area increased signif-
icantly after dobutamine infusion (1 .3 t 0.1 vs . 1 .9 -
0.1 cm). In the other two patients, who were symptomatic,
the mitral valve area did not change after dobutamine
infusion. These two patients were identified as having
"true - restenosis, and redilation of the mitral valve was
performed in both . The pulmonary/systemic: flow ratio by
oximetry was < 1 .2 in all patients before dobutamine infusion
and did not change after the infusion (Tables 3 and 4) .
Discussion
Our study demonstrated the existence of significant mitral
valve orifice variability with increased transmitral blood flow
in patients who had sustained symptomatic improvement
after balloon valvulotomy but not in those with symptomatic
rr°currence after the procedure or in those with untreated
severe mitrai stenosis .
Mitral valve reserve capacity . In normal subjects, in-
creased mitral valve flow with exercise is accomplished by
an increase in maximal diastolic mitral valve orifice (mitral
valve reserve capacity) (8) . in pa t ients with mitral stenosis,
increased mitral valve flow by exercise (9,10) or by isopro-
terenol (1 I) or dobutamine (12) infusion results in elevated
transmitral pressure gradients but minimal or no changes in
mitral valve area, similar to the results in our Group 1 . It is
generally accepted that the stenotic mitral valve orifice is
Z -
>
"Patientswnh mitral valve area (NIVA) s1 .5 cm' at baseline . Base = baseline
; Cl = cardiac index; Dohui = dobutamine ; EDP = erd-diastolic pressure ; Grad = gradient ; HR = heart rate ; MR = mitral resistance ;
MV = mitral valve ; hTVAA = mitral valve area change; PAP = pulmonary artery pressure
; PCWP = pulmonary capillary wedge pressure--, Pt = patient, SV = stroke volume .
Ch
6
Table 1 . Hemodynamic Variables at Baseline and After Dobutamine Infusion in 29 Patients With Mitral Balloon Valvulotomy (Group 2) :~ l3
HR Mean PAP Mean PCWP CI SV EDP Mean Grad, MV HOW MR Mean M'VA P
Pt
(beats/min)
(mm Hg) (mm Hg) (litersimin) (ml) (mm Hg)
(Mm Hg) Iml,"MiE" (dynes em s (Cm)
MVAI
No. Base Dobut Base Dobut
Base Dobut Base Dobut Base Dobut Base
Dobut
Base
Dobut Base Dubul Base Debut Base Dobut
(%)
1 107
147 26
	
25 17 14 4 .2 6,0 65 66
7 5 7 0 -171 396 34 .4 33 .7 2 .7 3 .3 22
2 92 135 19 18 13
12 5 .2 7,0 76 70 4 6 6 5 251 330 X1 .9 20
.2 2 .7 3 .9 44
3
71 100 15 15 11 11 3 .2 4 .9 73 80 1e
10 4
203
269 21 .2 24 .8 2 .8 3 .1 11
4
74
115
13 14 7 6 2 .3 4 .2 57 65 9 8 2 2
170
20 .7
15 .7
2
.4 2,9
21
5 76
150 26 34 18 30 3 .2
6
.7
72
76
7 6 8 18 +82 _393 58 .6 61 .1 1 .8 2 .4 33
6 8 4 150 18 16 15 15 3 .5 7 .4 73 86 5 5 10
7 /15 310 62 .0 30 .1 1 .8 3 .0 67
7 110 129
21 29 20 21 4 .0 6.3 46 63 8
8
10
-1 93 268
69 .1
44 .8 1 .6 2.3 44
8
87 125 15 14 11 11 3 .3 4 .3 58
53 6 6 5 4
196
220 34 .0 24 .2 2 .3 2.9 26
9 70 92 19 22
15 16 2 .3 2 .9 57 56 15 1 7
5 ~?3
233
53 .3 34 .3
1 .8
2 .5 39
10* 93 132
14 21 12 17 3 .7 5-1 53 52
7 7 14 135 203 69 .1 52 .5 1 .4 19 36
11 94 165 18 22 12 12
3 .1 4 .4 52 42 8
6 4
6
1744 3_2
30 .6
24 .8 2 .3 3 .4 47
12 88
132 16 16 7 F 2.9 4 .2 53 52
9 6 5
2
145 215 46 .0 24 .8 1 .7 2
.7
59
13 99 170 15
13 11
5
2.7 5 .5 43 51 6 5
4 3 175 200
30.5
20 .0
2 .3
3 .0
30
14 88 110
17 17 15 16 3.6
49 65 69 7 5 6 6 214 301 37.4 26 .6 2 .3 3 .1 35
1Y 85 146
23 40 20 32 2.8 4 .8 52 53
8 4
.1 19
35
182
234 139.2 199A 1 .1 1 .1 0
16 88
145 19 20 15 15 2
.7
4 .3
48 47 9 8 7 7 164 204 56 .9 45 .7 1 .(6 1 .9 19
17 89 133 18 20 14
14
2.5
4 .7 48 60 5 7 5 5 165 218 40 .4 30 .6 2 .0 2 .4 20
18 70 140
25 24 19 19 2 .0 3 .5 46 40 5
7
9 6
200 268 60
.0
39 .8
1 .8
2 .3
28
19*
70 138 30 44 23 34 2 .0 3 .8
47 45 8 9 14 22
188
235 99 .3 124 .8 1 .3 13 0
20 75 145 31
31
25 24
2 .2 3 .8 48 44 7 8 10
12
185
248 72 .1 64 .5
1 .6
1 .8
13
21 68 135 29 31 25 24 2 .9 12 66
48 9 9 9 9 205 298 58 .5 40 .3 2 .0 2 .5 25
22 80 138 28 L. 26 27
3 .8 4 .7 7C 50 10 9 8 8
200 1 17 53 .3
45.0
1 .9 2 .2
16
23 77 139 29 31 14 24 3 .5
4 .6 71 52 9 8 11 11 211
265
69 .5 55 .3 1 .7 2 .1 24
>
24* 68 125
25
24 18 18
3 .2 5_1 80 68 8 8
7 7
139
195 67 .1 47.9
1 .3
1 .8
39 's
25* 66
145 24 23 17 16 3 .3 5 .0 86
59 7 7 8 8 155 218 68 .8 48.9 1 .4 1 .9 36
26* 89
148 21 21 16 17 2.2 5 .9
41
64
5 7 7 6 132 211 70 .7 37.9 1 .3 2-1 62
27T 78 150 26 27 19 20 2.0
5,9 42 65 8 8 9 lip 144 234 83 .3 57.0 1 .3 1 .9 46
28 79 133 28 29 16 17 2.2 5 .6 41 62
9
8
6 184 244 43 .5 32.8 2.0 2 .4
20
29 89 130 27 25 14 16
2 .3 4 .8 41 61 9 9 7 6 200 266 46.7 30 .1 2 .1 2 .6 24
2
Meal 83 136 22
24
16 18
3 5 58 59
7.8 7 .6
8
9
183 255 56
46
1 .9
2 .4
31
±SD ±12 ±17 6 t8 ±5 ±7 ±0.8 ±1
±13 ±12 ±2 ±1 .7 ±3 ±7 ±34 ±55 ±25 ±36 ±0.5 ±0 .6 ±17
r- 0
Value < 0.00911 < TO NS < 0 .00m]
NS NS NS <
0.0001
< 0 .005 < 0 .00t
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W)IJIPI'AMINE
11
0 .0001
re 1. Change in mitral valve area (MVA) after €lobutamtne
infusion in Group 2 with mural balloon valvulntomy,
fixed in a maximally opened position in diastole, with no
reserve capacity. However, patients with milder degrees of
mitral stenosis may have some residual reserve capacity,
allowing an increase in mitral valve area during exercise, as
shown by Dahan et al . (13) . Using the continuity equation
method, they showed that patients with mild mitral stenosis
and more pliable mitral leaflets (as evaluated by echocardio-
graphic score) increased their mitral valve area significantly
on supine exercise compared with those with a more severe
degree of valvular narrowing . They also reported that al-
though the increase in mitral valve area was less marked
than that in normal subjects, it was .still correlated to the
increase in stroke volume during exercise . The results of
dobutamine infusion in our Group 2 support these findings .
In our study the mitral valve area increased by 0 .7 cm` in
Group 2 after dobutamine infusion in contrast to no signifi-
cant change in Group 1 . Furthermore, this increase in mitral
valve area correlated with the symptomatic status of the
patients. A significant increase in mitral valve area after
re 2 . Change in mitral valve area (MVA) after dobutamine
infusion in Group 1 with untreated mitral stenosis .
2 .0
1 .0
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BASELINE.
DOBUTAMINE
p = NS
2.4±0.6
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Table 3 . Oxygen Salutation and Pulmonary/Sysionic Flow Ratio
at Baseline and After Dobutamine Infusion in 10 Patients in
Group I
Qr Q, = puh11onary/',q ,.,1VnnC flov, ratio : Other ahbrcviations us in Table I .
dobutamine infusion was still observed in live patients with
asympWmatic restenosis after mitral balloon valvulotomy .
whereas no change was noted in two symptomatic patients
with a similar mitral valve area at baseline . Despite the
similar echocardiographic scores in Groups I and 2, the
balloon-induced commissural separation (14,15) allowed
greater flexibility of the leaflets in patients in Group 2,
resulting not only in a larger mitral valve area at rest, but
also in partial restoration of mitral valve reserve capacity .
Comparison with previous studies . Data on the variability
of mitral valve area with exercise in patients after mitral
balloon valvulotomy are conflicting . McKay et al . (16)
reported a statistically significant increase in mitral valve
area from 2 .0 to 2.4 cm2 with symptom-limited supine
bicycle exercise 3 months after mitral balloon valvulotomy,
although there was no change in mitral valve area at the
baseline test In our Group 2, a similar significant increase in
mitral valve area after dobutamine infusion was achieved
with less marked changes in the mitral valve gradients and
pulmonary pressures than those reported by McKay et al .
(16) . Dobutamine increases cardiac output, heart rate and
systolic blood pressure (17) in a manner similar to exercise
(18) . However, patients with mitral stenosis may show
different pulmonary hemodynamic responses to cate-
cholamine (isoproterenol or dobutamine) stress in that the
increase in pulmonary artery and wedge pressures and mitral
gradient may not be as prominent as with exercise (11),
especially in those with mild disease (12) .
Tamai et al . (19), in a study of patients performing a
supine bicycle exercise test 5 days after mitral balloon
valvulotomy, concluded that the mitral valve was maximally
open at rest and, there was nc , capacity to further dilate
during exercise, even after balloon valvulotomy . This was
based on the finding that the Doppler-estimated mitral valve
gradient increased, and the mitral flow velocity integral
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Abbreviations as in TabWS 1 and 3 .
decreased after exercise . These investigators did not use the
continuity equation method, which has been reported to be
the method of choice for the noninvasive determination of
mitral valve area during changing hemodynamic conditions
(10) .
Methodologic considerations with regard to mitral valve
area determination. The mitral valve resistance concept was
proposed by Beyer et al . (20) to avoid potential flow-
dependent errors in valve area calculations . They reported
that, in patients with successful balloon valvulotomy, iso-
proterenol infusion increased mitral valve area (Gorlin con-
stant) by 0 .23 cm
2 ,
whereas valve resistance did not change .
Our findings contradict their results in that mitral valve
resistance increased significantly after dobutamine infusion
in patients with untreated mitral stenosis and decreased in
those with successful valvulotomy . Cannon et al. (21) em-
phasized that the flow dependency of the Gorlin constant
resulted in a higher calculated valve area with increased flow
and suggested a modified formula . Paulus et al . (5),
however,
1695
Tablt~ 4. Oxygen Saturation and Pulmonary/Systemic Flow Ratio
at Baseline and After Dobutamine Infusion in 29 Patients in
Group 2
(hygen Saturation
117 )
Pt
No .
Superior Vena
Cava
Pulmonary
Artery Mixed Venous
Q
v
/Q,
Base Dobut Base Dobut Base Dobut
Base Dobut
1 59 68 62 68 60 68
1 .1 1 .0
2 62
71
65 70 64 72
1 .0 1 .0
3 68 75 71 74
68 76 1 .1 0 .9
4 59 72 66 70 60 72 1 .2
0 .9
5 63
75
65 73 63 75 1 .1 0 .9
6 64 77 67 74
65 76 1 .1 1 .0
7 66 77 67 75 67 76
1 .0 1 .0
8 67
73 68 72 68 74 1 .0
0 .9
9 69 75
73
76
70 75 1 .2 1 .3
10 6o 71 68 73
62
72
1 .2 1 .1
11 57 70 65 72 59 70
1 .2 Ll
12 58
71
66 72 60 72 1 .2 Lo
13 60 69
63
70
62
71 1
.2 1 .0
14 62 68 66 69 63 69 1,1 0 .9
15 4 71 66 70 65 71
1 A
0 .9
16 61 66 65 68 62 67 1 .1 1 .0
17
60 68
67
69 61
70
1 .1 110
18 60 69 66 68 61 69 1 .': 1 .0
19 58 68 65 71 60 70 1 . 1 .0
20 63
70
68 70 65 71 1 .2 1 .0
21 64 72 68 72
65
73 1 .1 1 .0
22 59 74 65 75 64) 77 1 .1 0 .9
23 60
71
62
72
60
71
1 .2 1 .1
24 62
70
63
71
62
70
1 .1 1 .1
25 58 72 62 71 59 72 1o 1 .0
26 57 64 60 68 59 66 1 .1
1 .1
27
62 70 66 71 62 71 1 .2 1 .0
28 61 70 66 72 62 70 1 .2 1 .1
29 64 72 67 71 65 73 1 .1 0 .9
Oxygen S aura non t'-11
Superior Vena
Cava
putnwmry
Mixed Venous
Q,; Q,
Anegv
No . Base DOW Base Dabut
Base Dobill
Base Dobatt
1 63 70 65 70 65 71
1 .0
1 .0
1 69 75 11 1 76 70 75 1 .0 1 .0
3 62 68
66 69
63 69 L] 0,9
4 64 71 66 70 65 71
1 .1
0 .9
5 61 66 63 68 62- 67
1 .1 1 .0
6 60 68 64 69 61 70 LI 1 .0
7 64 72
68
72
65
73
1 .1 L0
8 59 74 62 60 77 L I 0 .9
9 62 70 63 71 62 70 1 .0 1 .1
10 58 72 hi 71 19 72 11 1 .0
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reported a flow-dependent increase in aortic valve area after
balloon aortic valvulotomy, even after using the Cannon
formula . The flow dependency of the Gorlin constant has not
been studied in detail in mitral stenosis . Documentation of
significant orifice variability using the Gorlin formula only in
patients with sustained success after balloon valvulotomy
and not in those with untreated' mitral stenosis, despite the
significant increase in mitral flow in both groups in response
to dobutamine, argues against the effect of computation
errors. It is interesting that Dahan et al
. (13), using a
completely different method for calculating mitral valve
area, also reached a similar conclusion supporting the pres-
ence of mitral valve reserve capacity, even in untreated
mitral stenosis, Dahan et al . (13) found an inverse correlation
between the exercise-induced increase in mitral valve area
and the echocardiographic severity of mitral valve damage .
Our series consisted of relatively wrounger patients with
probably less severe mitral valvular and subvalvular involve-
ment than patients in other previously reported balloon
valvulotomy studies, especially in Western countries . It is
possible that the differences in the degree of mitral valve or
subvalvular damage determining the final extent of leaflet
mobility may partially account for the discrepancy between
our results and others .
Study limitations. The possible limitations of the Gorlin
formula for valve area determination were discussed in the
previous paragraph. The effects of an atrial septal defect
created during balloon valvulotomy on follow-up hemody-
namic function have not been studied in detail . In our study
the oximetric left to tight shunt was negligible before and
after dobutamine, and the presence of a small atria] septal
defect probably did not contribute to the left atrial pressure
changes. It is also known that most atrial septal defects
caused by balloon valvulotomy decrease in size during the
follow-up period (22,23). The main limitation of our study
the small number of patients with resteenosis. The
usefulness of dobutamine stress in determining or predicting
restenosis after balloon valvulotomy needs to be confirmed
in 1 1 itudinal studies.
C . Restoration of mitral valve reserve capacity
after mitral balloon valvulotomy may be important in in-
creasing mitral valve flow without further elevation of the
transmitral pressure gradient, thereby contributing to symp-
tomatic improvement in patients . Moreover, this phenome-
non may be important in defining restenosis after mitral
balloon valvulotomy . As we reported previously, the widely
u definition of restenosis on the basis of hemodynamic
function at rest may not correlate with symptomatic status
during follow-up (4) . Therefore, in evaluating the long-term
is of mitral balloon valvulotomy, determination of the
is response to dobutami a may be more clini-
cally relevant than an absolute cutoff value for mitral valve
JACC Vol. 22, No. 6
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